Access campaign

Swiss pharmaceutical corporation Roche must urgently share know-how and technology with broad range of manufacturers in low- and middle-income countries to scale up production and access As the World Health Organization (WHO) recommended tocilizumab today for people with severe COVID-19, Médecins...
The second wave of COVID-19 is reaching extremely alarming levels in India. As of 18 May, the total number of active COVID-19 cases in India is at 3,353,765. Médecins Sans Frontières (MSF) has scaled up medical intervention in Mumbai, while at the same time undertaking precautionary measures to...
MSF International President appeals to governments stonewalling on landmark proposal As governments prepare to meet for another round of talks at the World Trade Organization (WTO) tomorrow, Médecins Sans Frontières/Doctors Without Borders (MSF) urged the small number of governments that continue...
The US Food and Drug Administration (FDA) will meet tomorrow to discuss emergency use authorisation of the Johnson & Johnson (J&J) COVID-19 vaccine candidate. If the vaccine is approved, Médecins Sans Frontières/Doctors Without Borders (MSF) calls on J&J to send its first shipments to...
The COVAX Facility today announced the delivery of its first COVID-19 vaccine doses to Ghana. This first delivery from the COVAX Facility comes over two months after the first people started receiving COVID-19 vaccines in wealthy countries. Kate Elder, Senior Vaccines Policy Advisor, MSF Access...
Ahead of the next round of talks at the World Trade Organization (WTO) to discuss a proposal by South Africa and India to waive monopolies on COVID-19 medical tools during the pandemic, Médecins Sans Frontières/Doctors Without Borders (MSF) called on the wealthy countries opposing the proposal not...
As the US Food and Drug Administration (FDA) starts meeting today and later this month to discuss emergency use authorisation of both the Pfizer/BioNTech and Moderna COVID-19 vaccine candidates, Médecins Sans Frontières/Doctors Without Borders (MSF) warns that any eventual COVID-19 vaccine approval...
Terms of a deal disclosed show that we cannot rely on pharma’s goodwill to do the right thing, even in a pandemic. After the worrying terms of a deal struck between pharmaceutical corporation AstraZeneca and Brazilian public research body Fundação Oswaldo Cruz (Fiocruz) were disclosed recently,...
The pharmaceutical corporation Johnson & Johnson (J&J) today announced a reduced price of US$1.50* per day for the tuberculosis (TB) drug bedaquiline, which is an important step that should allow more people with drug-resistant forms of TB (DR-TB) to access this lifesaving drug. But the...
We're in a time of unprecedented mobilisation to tackle COVID-19. Governments and philanthropies have contributed billions to the research and development of COVID-19 vaccines, while Gavi 1 , the Vaccine Alliance, has recently launched a new fund – the COVAX Facility 2 – to make advance purchases...
Subscribe to RSS - Access campaign